You are here

Article info

Article menu
Basic tumor immunology
Original research
Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer

Authors

  • Maximilian Kießler Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Ioana Plesca Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Ulrich Sommer Institute of Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Rebekka Wehner Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, GermanyNational Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyGerman Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Friederike Wilczkowski Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Luise Müller Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Antje Tunger Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, GermanyNational Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Xixi Lai Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Anke Rentsch University Cancer Center, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Kenneth Peuker Department of Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanyCenter for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Sebastian Zeissig Department of Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanyCenter for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Adrian M Seifert National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Lena Seifert National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Jürgen Weitz National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyGerman Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Michael Bachmann National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyGerman Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, GermanyUniversity Cancer Center, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanyCenter for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, GermanyInstitute of Radiopharmaceutical Cancer Research, Helmholtz Center Dresden-Rossendorf (HZDR), Dresden, Germany PubMed articlesGoogle scholar articles
  • Martin Bornhäuser National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyGerman Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, GermanyUniversity Cancer Center, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanyDepartment of Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanyCenter for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Daniela Aust Institute of Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanyNational Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyGerman Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, GermanyTumor and normal tissue bank of the University Cancer Center, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Gustavo Baretton Institute of Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanyNational Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyGerman Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, GermanyTumor and normal tissue bank of the University Cancer Center, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Marc Schmitz Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, GermanyNational Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, GermanyGerman Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, GermanyCenter for Regenerative Therapies Dresden (CRTD), TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles

Citation

Kießler M, Plesca I, Sommer U, et al
Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer
Journal for ImmunoTherapy of Cancer 2021;9:e001813. doi: 10.1136/jitc-2020-001813
Online issue publication 
February 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.